Eric Riguet

After earning his European PhD in Paris and Marburg, Eric spent one year in London at Imperial College for postdoctoral research. After this academic experience, he went into the pharmaceutical industry in 1999 at Laboratoire Lafon as a Senior Scientist in a CNS business unit. Then in 2004, Eric had an opportunity to join Addex Pharmaceuticals as a project leader in a CNS business unit. After two and a half years with the team, he was able to deliver two clinical candidates. In 2008, Eric was promoted to group leader in newly formed business units in metabolic and inflammatory disorders, where his team was able to get a very nice proof of concept in two in vivo diabetes type 2 mice models.